Market Place
Sourcing Support
All News #Library
Rare Diseases
Chiesi Snaps Up Kalvista For $1.9B, Betting Big On Rare Disease
30 Apr 2026 //
BIOSPACE
Veld Pharma, Chiesi Expand Rare Disease Therapy Access in Africa
13 Apr 2026 //
GLOBENEWSWIRE
Chiesi Global Rare Diseases Gets FDA Nod For JUXTAPID
03 Mar 2026 //
GLOBENEWSWIRE
Chiesi Global Rare Diseases Strengthens Rare Disease Community
06 Feb 2026 //
PHARMIWEB
Chiesi Global Rare Diseases Receives Canada Approval of Elfabrio
16 Dec 2025 //
GLOBENEWSWIRE
NHS Scotland Recommends Procysbi For Nephropathic Cystinosis
13 Nov 2025 //
PHARMIWEB
Chiesi Enters Into License Agreement with Aliada Therapeutics
13 Nov 2025 //
GLOBENEWSWIRE
PANTHERx Rare Selected by Chiesi for Distribution of Mycapssa
13 Oct 2025 //
PR NEWSWIRE
Chiesi, Arbor Weave $2.1B Rare Disease Pact
06 Oct 2025 //
BIOSPACE
Chiesi Highlights EB Impact in Biotech Innovation Series Film
28 Jul 2025 //
GLOBENEWSWIRE
Chiesi Reports Phase 3 Results of ELFABRIO® in Fabry Disease
28 Oct 2024 //
PR NEWSWIRE
Chiesi Global Presents Long-Term Data on Treatment with Velmanase Alfa
08 Feb 2024 //
PR NEWSWIRE
Chiesi Global Rare Diseases Presents Results from PIII BALANCE & BRIGHT Studies
24 Feb 2023 //
PR NEWSWIRE
Chiesi Global Rare Diseases Announces Updated U.S. Prescribing FERRIPROX
05 Dec 2021 //
PRNEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.